Decompensated heart failure in the emergency department of a cardiology hospital.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 18592093)

Published in Arq Bras Cardiol on June 01, 2008

Authors

Sandrigo Mangini1, Fábio Serra Silveira, Christiano Pereira Silva, Petherson Suzano Grativvol, Luís Fernando Bernal da Costa Seguro, Sílvia Moreira Ayub Ferreira, Amílcar Oshiro Mocelin, Luiz Francisco Cardoso, Fernando Bacal, Edimar Alcides Bocchi

Author Affiliations

1: Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP - Brasil. sandrigomangini@cardiol.br

Articles by these authors

Impact of the severity of end-stage liver disease in cardiac structure and function. Ann Hepatol (2013) 2.37

Sildenafil vs. sodium before nitroprusside for the pulmonary hypertension reversibility test before cardiac transplantation. Arq Bras Cardiol (2012) 2.01

Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease. Int J Cardiol (2013) 1.98

[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]. Arq Bras Cardiol (2011) 1.90

[Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC]. Arq Bras Cardiol (2011) 1.64

Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial. Circ Heart Fail (2009) 1.62

Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology (2014) 1.60

Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant (2008) 1.55

[III Brazilian Guidelines on Chronic Heart Failure]. Arq Bras Cardiol (2009) 1.54

Nutritional status and adequacy of energy and nutrient intakes among heart failure patients. Arq Bras Cardiol (2009) 1.43

II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol (2011) 1.41

Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study. Eur J Heart Fail (2012) 1.40

Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial. Circ Heart Fail (2008) 1.31

[II Brazilian Guidelines for Cardiac Transplantation]. Arq Bras Cardiol (2010) 1.24

[Updating of the Brazilian guideline for chronic heart failure - 2012]. Arq Bras Cardiol (2012) 1.22

Effects of continuous vs. interval exercise training on blood pressure and arterial stiffness in treated hypertension. Hypertens Res (2010) 1.18

Antitrypanosomal agents: treatment or threat? Lancet (2010) 1.09

Cardiac dysfunction related to cirrhosis. Arq Bras Cardiol (2013) 1.07

Early-onset and late-onset heart failure after liver transplantation. Liver Transpl (2013) 1.07

[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol (2011) 1.06

Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire. Arq Bras Cardiol (2009) 1.05

Exhaled acetone as a new biomaker of heart failure severity. Chest (2012) 1.02

Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation (2002) 1.00

Effect of a sequential education and monitoring programme on quality-of-life components in heart failure. Eur J Heart Fail (2010) 1.00

Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis (2012) 1.00

I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol (2011) 0.99

MicroRNAs: new players in heart failure. Mol Biol Rep (2012) 0.97

The emerging role of miR-208a in the heart. DNA Cell Biol (2012) 0.97

Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients. Clinics (Sao Paulo) (2008) 0.95

Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure. Arq Bras Cardiol (2007) 0.93

Reproducibility of the self-controlled six-minute walking test in heart failure patients. Clinics (Sao Paulo) (2008) 0.92

Interrupted aortic arch with cardiac heart failure in young adult. Arq Bras Cardiol (2008) 0.91

Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial. PLoS Negl Trop Dis (2013) 0.91

I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol (2013) 0.90

Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol (2008) 0.90

I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure. Arq Bras Cardiol (2005) 0.90

Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failure. Int J Cardiol (2012) 0.89

MicroRNAs: a new paradigm in the treatment and diagnosis of heart failure? Arq Bras Cardiol (2012) 0.88

The Borg scale as an important tool of self-monitoring and self-regulation of exercise prescription in heart failure patients during hydrotherapy. A randomized blinded controlled trial. Circ J (2009) 0.87

Aerobic exercise prescription in adult heart transplant recipients: a review. Cardiovasc Ther (2010) 0.86

The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol (2006) 0.84

Impact of sublingual sildenafil on pulmonary hypertension in patients with heart failure. Arq Bras Cardiol (2009) 0.84

The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy. Clinics (Sao Paulo) (2008) 0.84

[Heart transplantation in a patient with endomyocardial fibrosis]. Arq Bras Cardiol (2005) 0.83

Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant (2010) 0.83

Norepinephrine remains increased in the six-minute walking test after heart transplantation. Clinics (Sao Paulo) (2010) 0.83

Impact of the Brazilian scientific publications on the recent scientific developments in cardiology. Arq Bras Cardiol (2009) 0.83

Randomized and comparative study between two intra-hospital exercise programs for heart transplant patients. Rev Bras Cir Cardiovasc (2013) 0.83

Study of pro-thrombotic and pro-inflammatory factors in Chagas cardiomyopathy. Arq Bras Cardiol (2010) 0.83

Can the cardiopulmonary 6-minute walk test reproduce the usual activities of patients with heart failure? Arq Bras Cardiol (2002) 0.82

Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients. Cardiol J (2009) 0.82

Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test. Int J Cardiol (2009) 0.82

[I Guideline of the perioperative evaluation]. Arq Bras Cardiol (2007) 0.82

Prognostic value of cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy in a non-beta-blocker therapy setting. Eur J Heart Fail (2008) 0.81

Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine. J Trop Med (2012) 0.81

The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Eur J Heart Fail (2005) 0.81

Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier. Clinics (Sao Paulo) (2012) 0.81

Physical training in Becker muscular dystrophy associated with heart failure. Arq Bras Cardiol (2011) 0.81

Hemodynamic response in one session of strength exercise with and without electrostimulation in heart failure patients: A randomized controlled trial. Cardiol J (2011) 0.81

Magnetic Resonance Imaging in Chronic Chagas' Disease: Correlation with Endomyocardial Biopsy Findings and Gallium-67 Cardiac Uptake. Echocardiography (1998) 0.80

Heart rate dynamics in heart transplantation patients during a treadmill cardiopulmonary exercise test: a pilot study. Cardiol J (2009) 0.80

Exercise training in Chagas' cardiomyopathy: trials are welcome for this neglected heart disease. Eur J Heart Fail (2010) 0.80

Genetic and ElectroNic medIcal records to predict oUtcomeS in Heart Failure patients (GENIUS-HF) - design and rationale. BMC Cardiovasc Disord (2014) 0.80

Qualitative and quantitative real time myocardial contrast echocardiography for detecting hibernating myocardium. Echocardiography (2011) 0.80

Validation of the London Chest Activity of Daily Living scale in patients with heart failure. J Rehabil Med (2010) 0.79

Benefits of exercise training in the treatment of heart failure: study with a control group. Arq Bras Cardiol (2002) 0.79

Physical exercise and microRNAs: new frontiers in heart failure. Arq Bras Cardiol (2012) 0.79

Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach. Clinics (Sao Paulo) (2013) 0.79

Pilates in heart failure patients: a randomized controlled pilot trial. Cardiovasc Ther (2011) 0.79

Preliminary in-hospital experience with a fully automatic external cardioverter-defibrillator. Resuscitation (2004) 0.79

Increased S100B serum levels in dilated cardiomyopathy patients. J Card Fail (2007) 0.78

Effects of bisoprolol on cardiac function and exercise in patients with heart failure. Arq Bras Cardiol (2007) 0.78

European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Eur Heart J Cardiovasc Imaging (2015) 0.78

Endoscopic left sympathetic blockade in the treatment for dilated cardiomyopathy. Arq Bras Cardiol (2010) 0.78

The carvedilol's beta-blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort. Cardiovasc Ther (2010) 0.78

The relationship between heart rate and oxygen consumption in heart transplant recipients during a cardiopulmonary exercise test: heart rate dynamic during exercise test. Int J Cardiol (2009) 0.78

Hydrotherapy in heart failure: a case report. Clinics (Sao Paulo) (2009) 0.78